| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstracts presented at the Annual Scientific Meeting of the Stroke Society of Australasia and Stroke Nursing Symposium, 2005
|
|
|
2006
|
36 |
2 |
p. A1-A14
|
artikel
|
| 2 |
An apparently sporadic paraganglioma with an SDHB gene germline mutation presenting at age 68 years
|
Elston, M. S.
|
|
2006
|
36 |
2 |
p. 129-131
|
artikel
|
| 3 |
Book Review
|
|
|
2006
|
36 |
2 |
p. 142
|
artikel
|
| 4 |
Cardiac amyloidosis—sustained clinical and free light chain response to low dose thalidomide and corticosteroids
|
Campbell, P.
|
|
2006
|
36 |
2 |
p. 137-139
|
artikel
|
| 5 |
Cardiac resynchronisation therapy for heart failure
|
Mariani, J. A.
|
|
2006
|
36 |
2 |
p. 114-123
|
artikel
|
| 6 |
Clinical findings in Niemann–Pick disease type B
|
|
|
2006
|
36 |
2 |
p. 135-136
|
artikel
|
| 7 |
Communication deficiencies in research and monitoring by ethics committees
|
Karunaratne, A. S.
|
|
2006
|
36 |
2 |
p. 86-91
|
artikel
|
| 8 |
Consent in crisis: the need to reconceptualize consent to tissue banking research
|
Lipworth, W.
|
|
2006
|
36 |
2 |
p. 124-128
|
artikel
|
| 9 |
Corrigendum
|
|
|
2006
|
36 |
2 |
p. 142-143
|
artikel
|
| 10 |
How have we been managing chronic obstructive pulmonary disease in Australia?
|
Matheson, M. C.
|
|
2006
|
36 |
2 |
p. 92-99
|
artikel
|
| 11 |
Management of chronic hepatitis B virus infection: a new era of disease control
|
Farrell, G. C.
|
|
2006
|
36 |
2 |
p. 100-113
|
artikel
|
| 12 |
Measurement of faecal fat excretion: an evaluation of attitudes and practices of Australian gastroenterologists
|
Lust, M.
|
|
2006
|
36 |
2 |
p. 77-85
|
artikel
|
| 13 |
Medication accuracy and general practitioner referral letters
|
Carney, S. L.
|
|
2006
|
36 |
2 |
p. 132-134
|
artikel
|
| 14 |
Monitoring medical research conduct: why, how and by whom?
|
Thomson, Colin
|
|
2006
|
36 |
2 |
p. 69-71
|
artikel
|
| 15 |
Obstructive sleep apnoea induced atrial fibrillation
|
Goldin, J.M.
|
|
2006
|
36 |
2 |
p. 136-137
|
artikel
|
| 16 |
Pharmaceutical Benefits Scheme criteria for the use of tumour necrosis factor-α inhibitors in the treatment of ankylosing spondylitis in Australia: are they evidence based?
|
Smith, M. D.
|
|
2006
|
36 |
2 |
p. 72-76
|
artikel
|
| 17 |
Stool antigen testing for the diagnosis and confirmation of eradication of Helicobacter pylori infection
|
Wallace, R. A.
|
|
2006
|
36 |
2 |
p. 139-141
|
artikel
|
Tijdschrift beschrijving